nodes	percent_of_prediction	percent_of_DWPC	metapath
Pioglitazone—Rosiglitazone—type 2 diabetes mellitus	0.293	1	CrCtD
Pioglitazone—PPAR gamma—Rosiglitazone—type 2 diabetes mellitus	0.126	0.333	CiPCiCtD
Pioglitazone—Thiazolidinediones—Rosiglitazone—type 2 diabetes mellitus	0.126	0.333	CiPCiCtD
Pioglitazone—Peroxisome Proliferator-activated Receptor Activity—Rosiglitazone—type 2 diabetes mellitus	0.126	0.333	CiPCiCtD
Pioglitazone—PPARG—type 2 diabetes mellitus	0.0589	0.699	CbGaD
Pioglitazone—CYP3A4—type 2 diabetes mellitus	0.0254	0.301	CbGaD
Pioglitazone—PPARG—Glipizide—type 2 diabetes mellitus	0.0222	0.127	CbGbCtD
Pioglitazone—PPARG—Repaglinide—type 2 diabetes mellitus	0.0194	0.111	CbGbCtD
Pioglitazone—PPARG—Rosiglitazone—type 2 diabetes mellitus	0.0162	0.0924	CbGbCtD
Pioglitazone—PPARG—Nateglinide—type 2 diabetes mellitus	0.0133	0.0759	CbGbCtD
Pioglitazone—SLCO1B3—Valsartan—type 2 diabetes mellitus	0.00843	0.0482	CbGbCtD
Pioglitazone—SLCO1B1—Repaglinide—type 2 diabetes mellitus	0.00666	0.0381	CbGbCtD
Pioglitazone—SLCO1B1—Rosiglitazone—type 2 diabetes mellitus	0.00556	0.0318	CbGbCtD
Pioglitazone—SLCO1B1—Valsartan—type 2 diabetes mellitus	0.00491	0.0281	CbGbCtD
Pioglitazone—SLCO1B3—Losartan—type 2 diabetes mellitus	0.00484	0.0277	CbGbCtD
Pioglitazone—PTGS1—Chlorpropamide—type 2 diabetes mellitus	0.00442	0.0252	CbGbCtD
Pioglitazone—PTGS1—Rosiglitazone—type 2 diabetes mellitus	0.00407	0.0233	CbGbCtD
Pioglitazone—CYP2C8—Sitagliptin—type 2 diabetes mellitus	0.00352	0.0202	CbGbCtD
Pioglitazone—PTGS1—Nateglinide—type 2 diabetes mellitus	0.00335	0.0191	CbGbCtD
Pioglitazone—PTGS1—Irbesartan—type 2 diabetes mellitus	0.00321	0.0183	CbGbCtD
Pioglitazone—SLCO1B1—Losartan—type 2 diabetes mellitus	0.00282	0.0161	CbGbCtD
Pioglitazone—CYP2C8—Repaglinide—type 2 diabetes mellitus	0.00282	0.0161	CbGbCtD
Pioglitazone—CYP2C19—Gliclazide—type 2 diabetes mellitus	0.00251	0.0144	CbGbCtD
Pioglitazone—CYP2C9—Glimepiride—type 2 diabetes mellitus	0.00246	0.0141	CbGbCtD
Pioglitazone—CYP2C8—Rosiglitazone—type 2 diabetes mellitus	0.00235	0.0134	CbGbCtD
Pioglitazone—CYP2C8—Tolbutamide—type 2 diabetes mellitus	0.00227	0.013	CbGbCtD
Pioglitazone—CYP2C9—Glipizide—type 2 diabetes mellitus	0.00225	0.0129	CbGbCtD
Pioglitazone—CYP2C19—Chlorpropamide—type 2 diabetes mellitus	0.00214	0.0122	CbGbCtD
Pioglitazone—CYP2C9—Gliclazide—type 2 diabetes mellitus	0.00209	0.012	CbGbCtD
Pioglitazone—CYP2C19—Rosiglitazone—type 2 diabetes mellitus	0.00197	0.0113	CbGbCtD
Pioglitazone—CYP2C19—Tolbutamide—type 2 diabetes mellitus	0.00191	0.0109	CbGbCtD
Pioglitazone—CYP2C8—Irbesartan—type 2 diabetes mellitus	0.00185	0.0106	CbGbCtD
Pioglitazone—CYP2C9—Chlorpropamide—type 2 diabetes mellitus	0.00178	0.0102	CbGbCtD
Pioglitazone—CYP2C9—Rosiglitazone—type 2 diabetes mellitus	0.00164	0.00938	CbGbCtD
Pioglitazone—CYP3A4—Linagliptin—type 2 diabetes mellitus	0.0016	0.00917	CbGbCtD
Pioglitazone—CYP2C9—Tolbutamide—type 2 diabetes mellitus	0.00158	0.00906	CbGbCtD
Pioglitazone—CYP2D6—Rosiglitazone—type 2 diabetes mellitus	0.0015	0.00858	CbGbCtD
Pioglitazone—CYP2C9—Valsartan—type 2 diabetes mellitus	0.00145	0.00828	CbGbCtD
Pioglitazone—CYP3A4—Sitagliptin—type 2 diabetes mellitus	0.00143	0.00817	CbGbCtD
Pioglitazone—CYP2C9—Nateglinide—type 2 diabetes mellitus	0.00135	0.0077	CbGbCtD
Pioglitazone—CYP3A4—Glipizide—type 2 diabetes mellitus	0.00131	0.00748	CbGbCtD
Pioglitazone—CYP2C9—Irbesartan—type 2 diabetes mellitus	0.00129	0.00738	CbGbCtD
Pioglitazone—CYP2D6—Nateglinide—type 2 diabetes mellitus	0.00123	0.00704	CbGbCtD
Pioglitazone—CYP2C8—Losartan—type 2 diabetes mellitus	0.00119	0.00682	CbGbCtD
Pioglitazone—CYP2D6—Irbesartan—type 2 diabetes mellitus	0.00118	0.00675	CbGbCtD
Pioglitazone—CYP3A4—Repaglinide—type 2 diabetes mellitus	0.00114	0.00653	CbGbCtD
Pioglitazone—CYP2C19—Glyburide—type 2 diabetes mellitus	0.00109	0.00626	CbGbCtD
Pioglitazone—CYP2C19—Losartan—type 2 diabetes mellitus	0.001	0.00572	CbGbCtD
Pioglitazone—CYP2C9—Glyburide—type 2 diabetes mellitus	0.00091	0.0052	CbGbCtD
Pioglitazone—PPARG—brown adipose tissue—type 2 diabetes mellitus	0.000871	0.168	CbGeAlD
Pioglitazone—CYP2C9—Losartan—type 2 diabetes mellitus	0.000832	0.00476	CbGbCtD
Pioglitazone—CYP3A4—Nateglinide—type 2 diabetes mellitus	0.000783	0.00448	CbGbCtD
Pioglitazone—CYP3A4—Irbesartan—type 2 diabetes mellitus	0.000751	0.00429	CbGbCtD
Pioglitazone—CYP3A4—Orlistat—type 2 diabetes mellitus	0.000751	0.00429	CbGbCtD
Pioglitazone—CYP3A4—Bromocriptine—type 2 diabetes mellitus	0.00071	0.00406	CbGbCtD
Pioglitazone—PPARG—leg—type 2 diabetes mellitus	0.0007	0.135	CbGeAlD
Pioglitazone—PPARG—hindlimb—type 2 diabetes mellitus	0.000626	0.12	CbGeAlD
Pioglitazone—CYP3A4—Glyburide—type 2 diabetes mellitus	0.000529	0.00302	CbGbCtD
Pioglitazone—CYP3A4—Losartan—type 2 diabetes mellitus	0.000484	0.00277	CbGbCtD
Pioglitazone—PPARG—artery—type 2 diabetes mellitus	0.000383	0.0738	CbGeAlD
Pioglitazone—PPARG—endothelium—type 2 diabetes mellitus	0.000324	0.0624	CbGeAlD
Pioglitazone—Rosiglitazone—PPARG—type 2 diabetes mellitus	0.000276	0.493	CrCbGaD
Pioglitazone—PTGS1—artery—type 2 diabetes mellitus	0.000205	0.0395	CbGeAlD
Pioglitazone—PPARG—islet of Langerhans—type 2 diabetes mellitus	0.000184	0.0355	CbGeAlD
Pioglitazone—Rosiglitazone—CYP1A2—type 2 diabetes mellitus	0.00018	0.321	CrCbGaD
Pioglitazone—PTGS1—endothelium—type 2 diabetes mellitus	0.000173	0.0333	CbGeAlD
Pioglitazone—SLCO1B3—liver—type 2 diabetes mellitus	0.000165	0.0318	CbGeAlD
Pioglitazone—SLCO1B1—kidney—type 2 diabetes mellitus	0.000151	0.0291	CbGeAlD
Pioglitazone—PPARG—cardiovascular system—type 2 diabetes mellitus	0.000133	0.0257	CbGeAlD
Pioglitazone—PPARG—kidney—type 2 diabetes mellitus	0.00013	0.0251	CbGeAlD
Pioglitazone—PPARG—pancreas—type 2 diabetes mellitus	0.00013	0.0249	CbGeAlD
Pioglitazone—PPARG—adipose tissue—type 2 diabetes mellitus	0.000118	0.0226	CbGeAlD
Pioglitazone—Rosiglitazone—ALB—type 2 diabetes mellitus	0.000104	0.186	CrCbGaD
Pioglitazone—SLCO1B1—liver—type 2 diabetes mellitus	9.55e-05	0.0184	CbGeAlD
Pioglitazone—CYP2C8—kidney—type 2 diabetes mellitus	8.6e-05	0.0166	CbGeAlD
Pioglitazone—PPARG—liver—type 2 diabetes mellitus	8.24e-05	0.0159	CbGeAlD
Pioglitazone—CYP2C9—cardiovascular system—type 2 diabetes mellitus	7.8e-05	0.015	CbGeAlD
Pioglitazone—PTGS1—cardiovascular system—type 2 diabetes mellitus	7.12e-05	0.0137	CbGeAlD
Pioglitazone—PTGS1—kidney—type 2 diabetes mellitus	6.97e-05	0.0134	CbGeAlD
Pioglitazone—PTGS1—adipose tissue—type 2 diabetes mellitus	6.28e-05	0.0121	CbGeAlD
Pioglitazone—CYP2C19—liver—type 2 diabetes mellitus	6.22e-05	0.012	CbGeAlD
Pioglitazone—CYP3A4—kidney—type 2 diabetes mellitus	5.82e-05	0.0112	CbGeAlD
Pioglitazone—CYP2D6—kidney—type 2 diabetes mellitus	5.73e-05	0.011	CbGeAlD
Pioglitazone—CYP2C8—liver—type 2 diabetes mellitus	5.43e-05	0.0105	CbGeAlD
Pioglitazone—CYP2C9—liver—type 2 diabetes mellitus	4.83e-05	0.00929	CbGeAlD
Pioglitazone—CYP3A4—liver—type 2 diabetes mellitus	3.68e-05	0.00709	CbGeAlD
Pioglitazone—CYP2D6—liver—type 2 diabetes mellitus	3.62e-05	0.00697	CbGeAlD
Pioglitazone—Nervous system disorder—Glyburide—type 2 diabetes mellitus	2.94e-05	0.000659	CcSEcCtD
Pioglitazone—Connective tissue disorder—Irbesartan—type 2 diabetes mellitus	2.94e-05	0.000659	CcSEcCtD
Pioglitazone—Angina pectoris—Ramipril—type 2 diabetes mellitus	2.94e-05	0.000659	CcSEcCtD
Pioglitazone—Urethral disorder—Irbesartan—type 2 diabetes mellitus	2.93e-05	0.000657	CcSEcCtD
Pioglitazone—Back pain—Valsartan—type 2 diabetes mellitus	2.93e-05	0.000657	CcSEcCtD
Pioglitazone—Dyspnoea—Bromocriptine—type 2 diabetes mellitus	2.92e-05	0.000655	CcSEcCtD
Pioglitazone—Muscle spasms—Valsartan—type 2 diabetes mellitus	2.91e-05	0.000653	CcSEcCtD
Pioglitazone—Bronchitis—Ramipril—type 2 diabetes mellitus	2.9e-05	0.00065	CcSEcCtD
Pioglitazone—Hyperhidrosis—Glyburide—type 2 diabetes mellitus	2.9e-05	0.00065	CcSEcCtD
Pioglitazone—Back pain—Orlistat—type 2 diabetes mellitus	2.9e-05	0.000649	CcSEcCtD
Pioglitazone—Urticaria—Glimepiride—type 2 diabetes mellitus	2.89e-05	0.000647	CcSEcCtD
Pioglitazone—Visual impairment—Irbesartan—type 2 diabetes mellitus	2.88e-05	0.000646	CcSEcCtD
Pioglitazone—Muscle spasms—Orlistat—type 2 diabetes mellitus	2.88e-05	0.000645	CcSEcCtD
Pioglitazone—Urticaria—Sitagliptin—type 2 diabetes mellitus	2.88e-05	0.000645	CcSEcCtD
Pioglitazone—Hypersensitivity—Glipizide—type 2 diabetes mellitus	2.87e-05	0.000643	CcSEcCtD
Pioglitazone—Immune system disorder—Metformin—type 2 diabetes mellitus	2.86e-05	0.000642	CcSEcCtD
Pioglitazone—Mediastinal disorder—Metformin—type 2 diabetes mellitus	2.86e-05	0.000641	CcSEcCtD
Pioglitazone—Hypertension—Gliclazide—type 2 diabetes mellitus	2.85e-05	0.000638	CcSEcCtD
Pioglitazone—Gastrointestinal disorder—Bromocriptine—type 2 diabetes mellitus	2.83e-05	0.000635	CcSEcCtD
Pioglitazone—Fatigue—Bromocriptine—type 2 diabetes mellitus	2.83e-05	0.000634	CcSEcCtD
Pioglitazone—Hepatitis—Losartan—type 2 diabetes mellitus	2.82e-05	0.000631	CcSEcCtD
Pioglitazone—Arthralgia—Gliclazide—type 2 diabetes mellitus	2.81e-05	0.00063	CcSEcCtD
Pioglitazone—Myalgia—Gliclazide—type 2 diabetes mellitus	2.81e-05	0.00063	CcSEcCtD
Pioglitazone—Chest pain—Gliclazide—type 2 diabetes mellitus	2.81e-05	0.00063	CcSEcCtD
Pioglitazone—Upper respiratory tract infection—Ramipril—type 2 diabetes mellitus	2.8e-05	0.000628	CcSEcCtD
Pioglitazone—Hypoaesthesia—Losartan—type 2 diabetes mellitus	2.8e-05	0.000628	CcSEcCtD
Pioglitazone—Asthenia—Glipizide—type 2 diabetes mellitus	2.8e-05	0.000627	CcSEcCtD
Pioglitazone—Pharyngitis—Losartan—type 2 diabetes mellitus	2.8e-05	0.000626	CcSEcCtD
Pioglitazone—Unspecified disorder of skin and subcutaneous tissue—Gliclazide—type 2 diabetes mellitus	2.79e-05	0.000625	CcSEcCtD
Pioglitazone—Headache—Rosiglitazone—type 2 diabetes mellitus	2.79e-05	0.000625	CcSEcCtD
Pioglitazone—Ill-defined disorder—Orlistat—type 2 diabetes mellitus	2.78e-05	0.000623	CcSEcCtD
Pioglitazone—Erectile dysfunction—Ramipril—type 2 diabetes mellitus	2.78e-05	0.000623	CcSEcCtD
Pioglitazone—Cardiac disorder—Irbesartan—type 2 diabetes mellitus	2.78e-05	0.000622	CcSEcCtD
Pioglitazone—Discomfort—Gliclazide—type 2 diabetes mellitus	2.78e-05	0.000622	CcSEcCtD
Pioglitazone—Angioedema—Valsartan—type 2 diabetes mellitus	2.77e-05	0.000621	CcSEcCtD
Pioglitazone—Malnutrition—Metformin—type 2 diabetes mellitus	2.76e-05	0.000619	CcSEcCtD
Pioglitazone—Weight increased—Ramipril—type 2 diabetes mellitus	2.75e-05	0.000615	CcSEcCtD
Pioglitazone—Angioedema—Orlistat—type 2 diabetes mellitus	2.74e-05	0.000613	CcSEcCtD
Pioglitazone—Musculoskeletal discomfort—Glyburide—type 2 diabetes mellitus	2.73e-05	0.000612	CcSEcCtD
Pioglitazone—Vertigo—Valsartan—type 2 diabetes mellitus	2.72e-05	0.00061	CcSEcCtD
Pioglitazone—Flatulence—Metformin—type 2 diabetes mellitus	2.72e-05	0.00061	CcSEcCtD
Pioglitazone—Feeling abnormal—Bromocriptine—type 2 diabetes mellitus	2.7e-05	0.000606	CcSEcCtD
Pioglitazone—Immune system disorder—Irbesartan—type 2 diabetes mellitus	2.7e-05	0.000606	CcSEcCtD
Pioglitazone—Malaise—Orlistat—type 2 diabetes mellitus	2.7e-05	0.000605	CcSEcCtD
Pioglitazone—Mediastinal disorder—Irbesartan—type 2 diabetes mellitus	2.7e-05	0.000604	CcSEcCtD
Pioglitazone—Vertigo—Orlistat—type 2 diabetes mellitus	2.69e-05	0.000603	CcSEcCtD
Pioglitazone—Hypersensitivity—Glimepiride—type 2 diabetes mellitus	2.68e-05	0.0006	CcSEcCtD
Pioglitazone—Infection—Gliclazide—type 2 diabetes mellitus	2.68e-05	0.0006	CcSEcCtD
Pioglitazone—Dyspnoea—Glyburide—type 2 diabetes mellitus	2.67e-05	0.000599	CcSEcCtD
Pioglitazone—Hypersensitivity—Sitagliptin—type 2 diabetes mellitus	2.67e-05	0.000599	CcSEcCtD
Pioglitazone—Diarrhoea—Glipizide—type 2 diabetes mellitus	2.67e-05	0.000598	CcSEcCtD
Pioglitazone—Muscle spasms—Metformin—type 2 diabetes mellitus	2.65e-05	0.000595	CcSEcCtD
Pioglitazone—Acute coronary syndrome—Ramipril—type 2 diabetes mellitus	2.65e-05	0.000594	CcSEcCtD
Pioglitazone—Nervous system disorder—Gliclazide—type 2 diabetes mellitus	2.64e-05	0.000592	CcSEcCtD
Pioglitazone—Myocardial infarction—Ramipril—type 2 diabetes mellitus	2.64e-05	0.000591	CcSEcCtD
Pioglitazone—Skin disorder—Gliclazide—type 2 diabetes mellitus	2.62e-05	0.000586	CcSEcCtD
Pioglitazone—Urinary tract infection—Ramipril—type 2 diabetes mellitus	2.61e-05	0.000586	CcSEcCtD
Pioglitazone—Asthenia—Glimepiride—type 2 diabetes mellitus	2.61e-05	0.000585	CcSEcCtD
Pioglitazone—Urticaria—Bromocriptine—type 2 diabetes mellitus	2.61e-05	0.000584	CcSEcCtD
Pioglitazone—Malnutrition—Irbesartan—type 2 diabetes mellitus	2.6e-05	0.000584	CcSEcCtD
Pioglitazone—Hyperhidrosis—Gliclazide—type 2 diabetes mellitus	2.6e-05	0.000583	CcSEcCtD
Pioglitazone—Asthenia—Sitagliptin—type 2 diabetes mellitus	2.6e-05	0.000583	CcSEcCtD
Pioglitazone—Gastrointestinal disorder—Glyburide—type 2 diabetes mellitus	2.59e-05	0.00058	CcSEcCtD
Pioglitazone—Myalgia—Valsartan—type 2 diabetes mellitus	2.58e-05	0.000578	CcSEcCtD
Pioglitazone—Chest pain—Valsartan—type 2 diabetes mellitus	2.58e-05	0.000578	CcSEcCtD
Pioglitazone—Arthralgia—Valsartan—type 2 diabetes mellitus	2.58e-05	0.000578	CcSEcCtD
Pioglitazone—Sweating—Ramipril—type 2 diabetes mellitus	2.58e-05	0.000578	CcSEcCtD
Pioglitazone—Dizziness—Glipizide—type 2 diabetes mellitus	2.58e-05	0.000577	CcSEcCtD
Pioglitazone—Flatulence—Irbesartan—type 2 diabetes mellitus	2.57e-05	0.000575	CcSEcCtD
Pioglitazone—Unspecified disorder of skin and subcutaneous tissue—Valsartan—type 2 diabetes mellitus	2.56e-05	0.000574	CcSEcCtD
Pioglitazone—Ill-defined disorder—Metformin—type 2 diabetes mellitus	2.56e-05	0.000574	CcSEcCtD
Pioglitazone—Chest pain—Orlistat—type 2 diabetes mellitus	2.55e-05	0.000572	CcSEcCtD
Pioglitazone—Myalgia—Orlistat—type 2 diabetes mellitus	2.55e-05	0.000572	CcSEcCtD
Pioglitazone—Unspecified disorder of skin and subcutaneous tissue—Orlistat—type 2 diabetes mellitus	2.53e-05	0.000568	CcSEcCtD
Pioglitazone—Sinusitis—Ramipril—type 2 diabetes mellitus	2.52e-05	0.000566	CcSEcCtD
Pioglitazone—Discomfort—Orlistat—type 2 diabetes mellitus	2.52e-05	0.000565	CcSEcCtD
Pioglitazone—Muscle spasms—Irbesartan—type 2 diabetes mellitus	2.5e-05	0.000561	CcSEcCtD
Pioglitazone—Malaise—Metformin—type 2 diabetes mellitus	2.49e-05	0.000558	CcSEcCtD
Pioglitazone—Diarrhoea—Glimepiride—type 2 diabetes mellitus	2.49e-05	0.000558	CcSEcCtD
Pioglitazone—Diarrhoea—Sitagliptin—type 2 diabetes mellitus	2.48e-05	0.000556	CcSEcCtD
Pioglitazone—Oedema—Valsartan—type 2 diabetes mellitus	2.47e-05	0.000554	CcSEcCtD
Pioglitazone—Anaphylactic shock—Valsartan—type 2 diabetes mellitus	2.47e-05	0.000554	CcSEcCtD
Pioglitazone—Feeling abnormal—Glyburide—type 2 diabetes mellitus	2.47e-05	0.000554	CcSEcCtD
Pioglitazone—Infection—Valsartan—type 2 diabetes mellitus	2.46e-05	0.000551	CcSEcCtD
Pioglitazone—Musculoskeletal discomfort—Gliclazide—type 2 diabetes mellitus	2.45e-05	0.00055	CcSEcCtD
Pioglitazone—Oedema—Orlistat—type 2 diabetes mellitus	2.44e-05	0.000548	CcSEcCtD
Pioglitazone—Anaphylactic shock—Orlistat—type 2 diabetes mellitus	2.44e-05	0.000548	CcSEcCtD
Pioglitazone—Headache—Glipizide—type 2 diabetes mellitus	2.44e-05	0.000547	CcSEcCtD
Pioglitazone—Insomnia—Gliclazide—type 2 diabetes mellitus	2.44e-05	0.000546	CcSEcCtD
Pioglitazone—Infection—Orlistat—type 2 diabetes mellitus	2.43e-05	0.000544	CcSEcCtD
Pioglitazone—Nervous system disorder—Valsartan—type 2 diabetes mellitus	2.43e-05	0.000544	CcSEcCtD
Pioglitazone—Ill-defined disorder—Irbesartan—type 2 diabetes mellitus	2.42e-05	0.000542	CcSEcCtD
Pioglitazone—Flatulence—Losartan—type 2 diabetes mellitus	2.42e-05	0.000541	CcSEcCtD
Pioglitazone—Hepatitis—Ramipril—type 2 diabetes mellitus	2.41e-05	0.000541	CcSEcCtD
Pioglitazone—Anaemia—Irbesartan—type 2 diabetes mellitus	2.41e-05	0.00054	CcSEcCtD
Pioglitazone—Dizziness—Glimepiride—type 2 diabetes mellitus	2.4e-05	0.000539	CcSEcCtD
Pioglitazone—Skin disorder—Valsartan—type 2 diabetes mellitus	2.4e-05	0.000539	CcSEcCtD
Pioglitazone—Dyspnoea—Gliclazide—type 2 diabetes mellitus	2.4e-05	0.000538	CcSEcCtD
Pioglitazone—Nervous system disorder—Orlistat—type 2 diabetes mellitus	2.4e-05	0.000537	CcSEcCtD
Pioglitazone—Dizziness—Sitagliptin—type 2 diabetes mellitus	2.4e-05	0.000537	CcSEcCtD
Pioglitazone—Hypertension—Metformin—type 2 diabetes mellitus	2.38e-05	0.000534	CcSEcCtD
Pioglitazone—Urticaria—Glyburide—type 2 diabetes mellitus	2.38e-05	0.000534	CcSEcCtD
Pioglitazone—Angioedema—Irbesartan—type 2 diabetes mellitus	2.38e-05	0.000533	CcSEcCtD
Pioglitazone—Oedema peripheral—Ramipril—type 2 diabetes mellitus	2.38e-05	0.000533	CcSEcCtD
Pioglitazone—Skin disorder—Orlistat—type 2 diabetes mellitus	2.37e-05	0.000532	CcSEcCtD
Pioglitazone—Connective tissue disorder—Ramipril—type 2 diabetes mellitus	2.37e-05	0.000532	CcSEcCtD
Pioglitazone—Back pain—Losartan—type 2 diabetes mellitus	2.37e-05	0.000531	CcSEcCtD
Pioglitazone—Hyperhidrosis—Orlistat—type 2 diabetes mellitus	2.36e-05	0.00053	CcSEcCtD
Pioglitazone—Muscle spasms—Losartan—type 2 diabetes mellitus	2.36e-05	0.000528	CcSEcCtD
Pioglitazone—Asthenia—Bromocriptine—type 2 diabetes mellitus	2.35e-05	0.000527	CcSEcCtD
Pioglitazone—Chest pain—Metformin—type 2 diabetes mellitus	2.35e-05	0.000527	CcSEcCtD
Pioglitazone—Myalgia—Metformin—type 2 diabetes mellitus	2.35e-05	0.000527	CcSEcCtD
Pioglitazone—Malaise—Irbesartan—type 2 diabetes mellitus	2.35e-05	0.000527	CcSEcCtD
Pioglitazone—Vertigo—Irbesartan—type 2 diabetes mellitus	2.34e-05	0.000525	CcSEcCtD
Pioglitazone—Unspecified disorder of skin and subcutaneous tissue—Metformin—type 2 diabetes mellitus	2.33e-05	0.000523	CcSEcCtD
Pioglitazone—Visual impairment—Ramipril—type 2 diabetes mellitus	2.33e-05	0.000522	CcSEcCtD
Pioglitazone—Gastrointestinal disorder—Gliclazide—type 2 diabetes mellitus	2.32e-05	0.000521	CcSEcCtD
Pioglitazone—Discomfort—Metformin—type 2 diabetes mellitus	2.32e-05	0.00052	CcSEcCtD
Pioglitazone—Fatigue—Gliclazide—type 2 diabetes mellitus	2.32e-05	0.00052	CcSEcCtD
Pioglitazone—Headache—Glimepiride—type 2 diabetes mellitus	2.28e-05	0.000511	CcSEcCtD
Pioglitazone—Ill-defined disorder—Losartan—type 2 diabetes mellitus	2.27e-05	0.00051	CcSEcCtD
Pioglitazone—Headache—Sitagliptin—type 2 diabetes mellitus	2.27e-05	0.000509	CcSEcCtD
Pioglitazone—Anaemia—Losartan—type 2 diabetes mellitus	2.27e-05	0.000508	CcSEcCtD
Pioglitazone—Musculoskeletal discomfort—Valsartan—type 2 diabetes mellitus	2.25e-05	0.000505	CcSEcCtD
Pioglitazone—Oedema—Metformin—type 2 diabetes mellitus	2.25e-05	0.000505	CcSEcCtD
Pioglitazone—Hypertension—Irbesartan—type 2 diabetes mellitus	2.25e-05	0.000504	CcSEcCtD
Pioglitazone—Diarrhoea—Bromocriptine—type 2 diabetes mellitus	2.24e-05	0.000503	CcSEcCtD
Pioglitazone—Angioedema—Losartan—type 2 diabetes mellitus	2.24e-05	0.000502	CcSEcCtD
Pioglitazone—Infection—Metformin—type 2 diabetes mellitus	2.24e-05	0.000502	CcSEcCtD
Pioglitazone—Insomnia—Valsartan—type 2 diabetes mellitus	2.24e-05	0.000502	CcSEcCtD
Pioglitazone—Musculoskeletal discomfort—Orlistat—type 2 diabetes mellitus	2.23e-05	0.000499	CcSEcCtD
Pioglitazone—Feeling abnormal—Gliclazide—type 2 diabetes mellitus	2.22e-05	0.000497	CcSEcCtD
Pioglitazone—Arthralgia—Irbesartan—type 2 diabetes mellitus	2.22e-05	0.000497	CcSEcCtD
Pioglitazone—Myalgia—Irbesartan—type 2 diabetes mellitus	2.22e-05	0.000497	CcSEcCtD
Pioglitazone—Chest pain—Irbesartan—type 2 diabetes mellitus	2.22e-05	0.000497	CcSEcCtD
Pioglitazone—Insomnia—Orlistat—type 2 diabetes mellitus	2.21e-05	0.000496	CcSEcCtD
Pioglitazone—Malaise—Losartan—type 2 diabetes mellitus	2.21e-05	0.000496	CcSEcCtD
Pioglitazone—Hypersensitivity—Glyburide—type 2 diabetes mellitus	2.21e-05	0.000495	CcSEcCtD
Pioglitazone—Nervous system disorder—Metformin—type 2 diabetes mellitus	2.21e-05	0.000495	CcSEcCtD
Pioglitazone—Dyspnoea—Valsartan—type 2 diabetes mellitus	2.21e-05	0.000494	CcSEcCtD
Pioglitazone—Vertigo—Losartan—type 2 diabetes mellitus	2.2e-05	0.000494	CcSEcCtD
Pioglitazone—Unspecified disorder of skin and subcutaneous tissue—Irbesartan—type 2 diabetes mellitus	2.2e-05	0.000494	CcSEcCtD
Pioglitazone—Discomfort—Irbesartan—type 2 diabetes mellitus	2.19e-05	0.000491	CcSEcCtD
Pioglitazone—Skin disorder—Metformin—type 2 diabetes mellitus	2.19e-05	0.00049	CcSEcCtD
Pioglitazone—Immune system disorder—Ramipril—type 2 diabetes mellitus	2.18e-05	0.000489	CcSEcCtD
Pioglitazone—Hyperhidrosis—Metformin—type 2 diabetes mellitus	2.18e-05	0.000488	CcSEcCtD
Pioglitazone—Mediastinal disorder—Ramipril—type 2 diabetes mellitus	2.18e-05	0.000488	CcSEcCtD
Pioglitazone—Dizziness—Bromocriptine—type 2 diabetes mellitus	2.17e-05	0.000486	CcSEcCtD
Pioglitazone—Asthenia—Glyburide—type 2 diabetes mellitus	2.15e-05	0.000482	CcSEcCtD
Pioglitazone—Urticaria—Gliclazide—type 2 diabetes mellitus	2.14e-05	0.000479	CcSEcCtD
Pioglitazone—Gastrointestinal disorder—Valsartan—type 2 diabetes mellitus	2.14e-05	0.000479	CcSEcCtD
Pioglitazone—Fatigue—Valsartan—type 2 diabetes mellitus	2.13e-05	0.000478	CcSEcCtD
Pioglitazone—Anaphylactic shock—Irbesartan—type 2 diabetes mellitus	2.13e-05	0.000477	CcSEcCtD
Pioglitazone—Oedema—Irbesartan—type 2 diabetes mellitus	2.13e-05	0.000477	CcSEcCtD
Pioglitazone—Infection—Irbesartan—type 2 diabetes mellitus	2.11e-05	0.000473	CcSEcCtD
Pioglitazone—Gastrointestinal disorder—Orlistat—type 2 diabetes mellitus	2.11e-05	0.000473	CcSEcCtD
Pioglitazone—Fatigue—Orlistat—type 2 diabetes mellitus	2.11e-05	0.000472	CcSEcCtD
Pioglitazone—Malnutrition—Ramipril—type 2 diabetes mellitus	2.1e-05	0.000471	CcSEcCtD
Pioglitazone—Arthralgia—Losartan—type 2 diabetes mellitus	2.09e-05	0.000468	CcSEcCtD
Pioglitazone—Chest pain—Losartan—type 2 diabetes mellitus	2.09e-05	0.000468	CcSEcCtD
Pioglitazone—Myalgia—Losartan—type 2 diabetes mellitus	2.09e-05	0.000468	CcSEcCtD
Pioglitazone—Nervous system disorder—Irbesartan—type 2 diabetes mellitus	2.08e-05	0.000467	CcSEcCtD
Pioglitazone—Skin disorder—Irbesartan—type 2 diabetes mellitus	2.07e-05	0.000463	CcSEcCtD
Pioglitazone—Discomfort—Losartan—type 2 diabetes mellitus	2.06e-05	0.000462	CcSEcCtD
Pioglitazone—Hyperhidrosis—Irbesartan—type 2 diabetes mellitus	2.06e-05	0.000461	CcSEcCtD
Pioglitazone—Headache—Bromocriptine—type 2 diabetes mellitus	2.05e-05	0.000461	CcSEcCtD
Pioglitazone—Musculoskeletal discomfort—Metformin—type 2 diabetes mellitus	2.05e-05	0.00046	CcSEcCtD
Pioglitazone—Diarrhoea—Glyburide—type 2 diabetes mellitus	2.05e-05	0.00046	CcSEcCtD
Pioglitazone—Muscle spasms—Ramipril—type 2 diabetes mellitus	2.02e-05	0.000453	CcSEcCtD
Pioglitazone—Feeling abnormal—Orlistat—type 2 diabetes mellitus	2.01e-05	0.000451	CcSEcCtD
Pioglitazone—Dyspnoea—Metformin—type 2 diabetes mellitus	2.01e-05	0.00045	CcSEcCtD
Pioglitazone—Anaphylactic shock—Losartan—type 2 diabetes mellitus	2e-05	0.000448	CcSEcCtD
Pioglitazone—Oedema—Losartan—type 2 diabetes mellitus	2e-05	0.000448	CcSEcCtD
Pioglitazone—Infection—Losartan—type 2 diabetes mellitus	1.99e-05	0.000446	CcSEcCtD
Pioglitazone—Hypersensitivity—Gliclazide—type 2 diabetes mellitus	1.98e-05	0.000445	CcSEcCtD
Pioglitazone—Urticaria—Valsartan—type 2 diabetes mellitus	1.97e-05	0.00044	CcSEcCtD
Pioglitazone—Nervous system disorder—Losartan—type 2 diabetes mellitus	1.96e-05	0.00044	CcSEcCtD
Pioglitazone—Ill-defined disorder—Ramipril—type 2 diabetes mellitus	1.95e-05	0.000437	CcSEcCtD
Pioglitazone—Gastrointestinal disorder—Metformin—type 2 diabetes mellitus	1.94e-05	0.000436	CcSEcCtD
Pioglitazone—Fatigue—Metformin—type 2 diabetes mellitus	1.94e-05	0.000435	CcSEcCtD
Pioglitazone—Urticaria—Orlistat—type 2 diabetes mellitus	1.94e-05	0.000435	CcSEcCtD
Pioglitazone—Musculoskeletal discomfort—Irbesartan—type 2 diabetes mellitus	1.94e-05	0.000434	CcSEcCtD
Pioglitazone—Hyperhidrosis—Losartan—type 2 diabetes mellitus	1.93e-05	0.000434	CcSEcCtD
Pioglitazone—Asthenia—Gliclazide—type 2 diabetes mellitus	1.93e-05	0.000433	CcSEcCtD
Pioglitazone—Angioedema—Ramipril—type 2 diabetes mellitus	1.92e-05	0.000431	CcSEcCtD
Pioglitazone—Malaise—Ramipril—type 2 diabetes mellitus	1.9e-05	0.000425	CcSEcCtD
Pioglitazone—Dyspnoea—Irbesartan—type 2 diabetes mellitus	1.9e-05	0.000425	CcSEcCtD
Pioglitazone—Vertigo—Ramipril—type 2 diabetes mellitus	1.89e-05	0.000423	CcSEcCtD
Pioglitazone—Headache—Glyburide—type 2 diabetes mellitus	1.88e-05	0.000421	CcSEcCtD
Pioglitazone—Feeling abnormal—Metformin—type 2 diabetes mellitus	1.86e-05	0.000416	CcSEcCtD
Pioglitazone—Diarrhoea—Gliclazide—type 2 diabetes mellitus	1.84e-05	0.000413	CcSEcCtD
Pioglitazone—Gastrointestinal disorder—Irbesartan—type 2 diabetes mellitus	1.84e-05	0.000411	CcSEcCtD
Pioglitazone—Fatigue—Irbesartan—type 2 diabetes mellitus	1.83e-05	0.000411	CcSEcCtD
Pioglitazone—Musculoskeletal discomfort—Losartan—type 2 diabetes mellitus	1.82e-05	0.000409	CcSEcCtD
Pioglitazone—Hypersensitivity—Valsartan—type 2 diabetes mellitus	1.82e-05	0.000409	CcSEcCtD
Pioglitazone—Insomnia—Losartan—type 2 diabetes mellitus	1.81e-05	0.000406	CcSEcCtD
Pioglitazone—Hypersensitivity—Orlistat—type 2 diabetes mellitus	1.8e-05	0.000404	CcSEcCtD
Pioglitazone—Urticaria—Metformin—type 2 diabetes mellitus	1.79e-05	0.000401	CcSEcCtD
Pioglitazone—Arthralgia—Ramipril—type 2 diabetes mellitus	1.79e-05	0.000401	CcSEcCtD
Pioglitazone—Chest pain—Ramipril—type 2 diabetes mellitus	1.79e-05	0.000401	CcSEcCtD
Pioglitazone—Myalgia—Ramipril—type 2 diabetes mellitus	1.79e-05	0.000401	CcSEcCtD
Pioglitazone—Dyspnoea—Losartan—type 2 diabetes mellitus	1.78e-05	0.0004	CcSEcCtD
Pioglitazone—Dizziness—Gliclazide—type 2 diabetes mellitus	1.78e-05	0.000399	CcSEcCtD
Pioglitazone—Unspecified disorder of skin and subcutaneous tissue—Ramipril—type 2 diabetes mellitus	1.78e-05	0.000398	CcSEcCtD
Pioglitazone—Asthenia—Valsartan—type 2 diabetes mellitus	1.77e-05	0.000398	CcSEcCtD
Pioglitazone—Discomfort—Ramipril—type 2 diabetes mellitus	1.77e-05	0.000396	CcSEcCtD
Pioglitazone—Asthenia—Orlistat—type 2 diabetes mellitus	1.75e-05	0.000393	CcSEcCtD
Pioglitazone—Feeling abnormal—Irbesartan—type 2 diabetes mellitus	1.75e-05	0.000393	CcSEcCtD
Pioglitazone—Fatigue—Losartan—type 2 diabetes mellitus	1.72e-05	0.000387	CcSEcCtD
Pioglitazone—Oedema—Ramipril—type 2 diabetes mellitus	1.72e-05	0.000385	CcSEcCtD
Pioglitazone—Anaphylactic shock—Ramipril—type 2 diabetes mellitus	1.72e-05	0.000385	CcSEcCtD
Pioglitazone—Diarrhoea—Valsartan—type 2 diabetes mellitus	1.69e-05	0.000379	CcSEcCtD
Pioglitazone—Urticaria—Irbesartan—type 2 diabetes mellitus	1.69e-05	0.000379	CcSEcCtD
Pioglitazone—Headache—Gliclazide—type 2 diabetes mellitus	1.69e-05	0.000378	CcSEcCtD
Pioglitazone—Nervous system disorder—Ramipril—type 2 diabetes mellitus	1.68e-05	0.000377	CcSEcCtD
Pioglitazone—Diarrhoea—Orlistat—type 2 diabetes mellitus	1.67e-05	0.000375	CcSEcCtD
Pioglitazone—Skin disorder—Ramipril—type 2 diabetes mellitus	1.67e-05	0.000373	CcSEcCtD
Pioglitazone—Hyperhidrosis—Ramipril—type 2 diabetes mellitus	1.66e-05	0.000372	CcSEcCtD
Pioglitazone—Feeling abnormal—Losartan—type 2 diabetes mellitus	1.65e-05	0.00037	CcSEcCtD
Pioglitazone—Dizziness—Valsartan—type 2 diabetes mellitus	1.64e-05	0.000367	CcSEcCtD
Pioglitazone—Dizziness—Orlistat—type 2 diabetes mellitus	1.62e-05	0.000362	CcSEcCtD
Pioglitazone—Asthenia—Metformin—type 2 diabetes mellitus	1.62e-05	0.000362	CcSEcCtD
Pioglitazone—Urticaria—Losartan—type 2 diabetes mellitus	1.59e-05	0.000356	CcSEcCtD
Pioglitazone—Hypersensitivity—Irbesartan—type 2 diabetes mellitus	1.57e-05	0.000351	CcSEcCtD
Pioglitazone—Musculoskeletal discomfort—Ramipril—type 2 diabetes mellitus	1.56e-05	0.00035	CcSEcCtD
Pioglitazone—Insomnia—Ramipril—type 2 diabetes mellitus	1.55e-05	0.000348	CcSEcCtD
Pioglitazone—Headache—Valsartan—type 2 diabetes mellitus	1.55e-05	0.000347	CcSEcCtD
Pioglitazone—Diarrhoea—Metformin—type 2 diabetes mellitus	1.54e-05	0.000345	CcSEcCtD
Pioglitazone—Headache—Orlistat—type 2 diabetes mellitus	1.53e-05	0.000343	CcSEcCtD
Pioglitazone—Dyspnoea—Ramipril—type 2 diabetes mellitus	1.53e-05	0.000343	CcSEcCtD
Pioglitazone—Asthenia—Irbesartan—type 2 diabetes mellitus	1.53e-05	0.000342	CcSEcCtD
Pioglitazone—Dizziness—Metformin—type 2 diabetes mellitus	1.49e-05	0.000334	CcSEcCtD
Pioglitazone—Gastrointestinal disorder—Ramipril—type 2 diabetes mellitus	1.48e-05	0.000332	CcSEcCtD
Pioglitazone—Fatigue—Ramipril—type 2 diabetes mellitus	1.48e-05	0.000332	CcSEcCtD
Pioglitazone—Hypersensitivity—Losartan—type 2 diabetes mellitus	1.47e-05	0.00033	CcSEcCtD
Pioglitazone—Diarrhoea—Irbesartan—type 2 diabetes mellitus	1.45e-05	0.000326	CcSEcCtD
Pioglitazone—Asthenia—Losartan—type 2 diabetes mellitus	1.44e-05	0.000322	CcSEcCtD
Pioglitazone—Feeling abnormal—Ramipril—type 2 diabetes mellitus	1.41e-05	0.000317	CcSEcCtD
Pioglitazone—Headache—Metformin—type 2 diabetes mellitus	1.41e-05	0.000316	CcSEcCtD
Pioglitazone—Dizziness—Irbesartan—type 2 diabetes mellitus	1.41e-05	0.000315	CcSEcCtD
Pioglitazone—Diarrhoea—Losartan—type 2 diabetes mellitus	1.37e-05	0.000307	CcSEcCtD
Pioglitazone—Urticaria—Ramipril—type 2 diabetes mellitus	1.36e-05	0.000305	CcSEcCtD
Pioglitazone—Headache—Irbesartan—type 2 diabetes mellitus	1.33e-05	0.000299	CcSEcCtD
Pioglitazone—Dizziness—Losartan—type 2 diabetes mellitus	1.32e-05	0.000297	CcSEcCtD
Pioglitazone—Hypersensitivity—Ramipril—type 2 diabetes mellitus	1.26e-05	0.000283	CcSEcCtD
Pioglitazone—Headache—Losartan—type 2 diabetes mellitus	1.25e-05	0.000281	CcSEcCtD
Pioglitazone—Asthenia—Ramipril—type 2 diabetes mellitus	1.23e-05	0.000276	CcSEcCtD
Pioglitazone—Diarrhoea—Ramipril—type 2 diabetes mellitus	1.17e-05	0.000263	CcSEcCtD
Pioglitazone—Dizziness—Ramipril—type 2 diabetes mellitus	1.13e-05	0.000254	CcSEcCtD
Pioglitazone—Headache—Ramipril—type 2 diabetes mellitus	1.07e-05	0.000241	CcSEcCtD
Pioglitazone—CYP2C9—Metabolism—SLC2A2—type 2 diabetes mellitus	1.41e-06	7.34e-05	CbGpPWpGaD
Pioglitazone—PTGS1—Metabolism—MTHFR—type 2 diabetes mellitus	1.41e-06	7.33e-05	CbGpPWpGaD
Pioglitazone—PPARG—Metabolism—NOS3—type 2 diabetes mellitus	1.4e-06	7.29e-05	CbGpPWpGaD
Pioglitazone—PPARG—Metabolism—PIK3R1—type 2 diabetes mellitus	1.4e-06	7.29e-05	CbGpPWpGaD
Pioglitazone—CYP2D6—Metabolism—CPT1A—type 2 diabetes mellitus	1.4e-06	7.26e-05	CbGpPWpGaD
Pioglitazone—CYP2D6—Metabolism—MTR—type 2 diabetes mellitus	1.4e-06	7.26e-05	CbGpPWpGaD
Pioglitazone—CYP2C9—Metabolism—CPT1A—type 2 diabetes mellitus	1.38e-06	7.19e-05	CbGpPWpGaD
Pioglitazone—CYP2C9—Metabolism—MTR—type 2 diabetes mellitus	1.38e-06	7.19e-05	CbGpPWpGaD
Pioglitazone—PTGS1—Metabolism—PPARA—type 2 diabetes mellitus	1.38e-06	7.19e-05	CbGpPWpGaD
Pioglitazone—CYP2D6—Metabolism—NAMPT—type 2 diabetes mellitus	1.37e-06	7.12e-05	CbGpPWpGaD
Pioglitazone—CYP3A4—Metabolism—COX2—type 2 diabetes mellitus	1.36e-06	7.09e-05	CbGpPWpGaD
Pioglitazone—CYP3A4—Metabolism—SLC5A2—type 2 diabetes mellitus	1.36e-06	7.09e-05	CbGpPWpGaD
Pioglitazone—CYP2D6—Metabolism—LIPC—type 2 diabetes mellitus	1.36e-06	7.07e-05	CbGpPWpGaD
Pioglitazone—CYP2D6—Metabolism—HBA1—type 2 diabetes mellitus	1.36e-06	7.07e-05	CbGpPWpGaD
Pioglitazone—CYP2D6—Metabolism—GCK—type 2 diabetes mellitus	1.36e-06	7.07e-05	CbGpPWpGaD
Pioglitazone—CYP2C8—Metabolism—CYP2E1—type 2 diabetes mellitus	1.36e-06	7.07e-05	CbGpPWpGaD
Pioglitazone—CYP2C9—Metabolism—NAMPT—type 2 diabetes mellitus	1.36e-06	7.05e-05	CbGpPWpGaD
Pioglitazone—CYP2D6—Metabolism—CYP11A1—type 2 diabetes mellitus	1.35e-06	7.03e-05	CbGpPWpGaD
Pioglitazone—CYP2C9—Metabolism of lipids and lipoproteins—PPARG—type 2 diabetes mellitus	1.35e-06	7.01e-05	CbGpPWpGaD
Pioglitazone—CYP2C9—Metabolism—GCK—type 2 diabetes mellitus	1.35e-06	7.01e-05	CbGpPWpGaD
Pioglitazone—CYP2C9—Metabolism—LIPC—type 2 diabetes mellitus	1.35e-06	7.01e-05	CbGpPWpGaD
Pioglitazone—CYP2C9—Metabolism—HBA1—type 2 diabetes mellitus	1.35e-06	7.01e-05	CbGpPWpGaD
Pioglitazone—CYP2C8—Metabolism—CYP1A2—type 2 diabetes mellitus	1.34e-06	6.99e-05	CbGpPWpGaD
Pioglitazone—CYP2C8—Metabolism—SLC2A1—type 2 diabetes mellitus	1.34e-06	6.99e-05	CbGpPWpGaD
Pioglitazone—CYP2C9—Metabolism—CYP11A1—type 2 diabetes mellitus	1.34e-06	6.97e-05	CbGpPWpGaD
Pioglitazone—CYP3A4—Metabolism—NCOA6—type 2 diabetes mellitus	1.34e-06	6.96e-05	CbGpPWpGaD
Pioglitazone—PTGS1—Metabolism—AGT—type 2 diabetes mellitus	1.34e-06	6.96e-05	CbGpPWpGaD
Pioglitazone—CYP2C19—Metabolism of lipids and lipoproteins—ALB—type 2 diabetes mellitus	1.33e-06	6.92e-05	CbGpPWpGaD
Pioglitazone—CYP2D6—Metabolism—SLC9A1—type 2 diabetes mellitus	1.33e-06	6.9e-05	CbGpPWpGaD
Pioglitazone—CYP2C19—Metabolism—PSMD6—type 2 diabetes mellitus	1.33e-06	6.9e-05	CbGpPWpGaD
Pioglitazone—CYP2C19—Metabolism—SREBF1—type 2 diabetes mellitus	1.33e-06	6.9e-05	CbGpPWpGaD
Pioglitazone—CYP2C19—Metabolism—SNAP25—type 2 diabetes mellitus	1.33e-06	6.9e-05	CbGpPWpGaD
Pioglitazone—PTGS1—Metabolism—CALM1—type 2 diabetes mellitus	1.32e-06	6.84e-05	CbGpPWpGaD
Pioglitazone—CYP3A4—Metabolism—HSD11B1—type 2 diabetes mellitus	1.32e-06	6.84e-05	CbGpPWpGaD
Pioglitazone—CYP3A4—Metabolism—UCP2—type 2 diabetes mellitus	1.32e-06	6.84e-05	CbGpPWpGaD
Pioglitazone—CYP3A4—Metabolism—UCP3—type 2 diabetes mellitus	1.32e-06	6.84e-05	CbGpPWpGaD
Pioglitazone—CYP2C9—Metabolism—SLC9A1—type 2 diabetes mellitus	1.32e-06	6.84e-05	CbGpPWpGaD
Pioglitazone—CYP2D6—Metabolism—CETP—type 2 diabetes mellitus	1.31e-06	6.82e-05	CbGpPWpGaD
Pioglitazone—PTGS1—Metabolism—APOE—type 2 diabetes mellitus	1.31e-06	6.82e-05	CbGpPWpGaD
Pioglitazone—CYP2C8—Metabolism—CYP3A4—type 2 diabetes mellitus	1.31e-06	6.81e-05	CbGpPWpGaD
Pioglitazone—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—type 2 diabetes mellitus	1.3e-06	6.78e-05	CbGpPWpGaD
Pioglitazone—CYP2C19—Metabolism—CTGF—type 2 diabetes mellitus	1.3e-06	6.77e-05	CbGpPWpGaD
Pioglitazone—CYP2C9—Metabolism—CETP—type 2 diabetes mellitus	1.3e-06	6.76e-05	CbGpPWpGaD
Pioglitazone—PTGS1—Metabolism—APOA1—type 2 diabetes mellitus	1.3e-06	6.74e-05	CbGpPWpGaD
Pioglitazone—CYP2C19—Metabolism—HMGCR—type 2 diabetes mellitus	1.29e-06	6.71e-05	CbGpPWpGaD
Pioglitazone—CYP2C8—Metabolism—SLC2A4—type 2 diabetes mellitus	1.29e-06	6.7e-05	CbGpPWpGaD
Pioglitazone—CYP2C8—Metabolism—GCG—type 2 diabetes mellitus	1.29e-06	6.7e-05	CbGpPWpGaD
Pioglitazone—SLCO1B1—Metabolism—PPARG—type 2 diabetes mellitus	1.29e-06	6.68e-05	CbGpPWpGaD
Pioglitazone—PPARG—Metabolism—PTGS2—type 2 diabetes mellitus	1.28e-06	6.67e-05	CbGpPWpGaD
Pioglitazone—CYP2C19—Metabolism of lipids and lipoproteins—PIK3R1—type 2 diabetes mellitus	1.27e-06	6.62e-05	CbGpPWpGaD
Pioglitazone—CYP2C19—Metabolism—ADRA2A—type 2 diabetes mellitus	1.26e-06	6.56e-05	CbGpPWpGaD
Pioglitazone—SLCO1B1—Metabolism—INS—type 2 diabetes mellitus	1.26e-06	6.55e-05	CbGpPWpGaD
Pioglitazone—CYP3A4—Metabolism—PCK1—type 2 diabetes mellitus	1.24e-06	6.43e-05	CbGpPWpGaD
Pioglitazone—CYP2D6—Metabolism—SREBF1—type 2 diabetes mellitus	1.22e-06	6.34e-05	CbGpPWpGaD
Pioglitazone—CYP2D6—Metabolism—SNAP25—type 2 diabetes mellitus	1.22e-06	6.34e-05	CbGpPWpGaD
Pioglitazone—CYP2D6—Metabolism—PSMD6—type 2 diabetes mellitus	1.22e-06	6.34e-05	CbGpPWpGaD
Pioglitazone—CYP2C19—Metabolism—CYP2E1—type 2 diabetes mellitus	1.21e-06	6.31e-05	CbGpPWpGaD
Pioglitazone—CYP2C9—Metabolism of lipids and lipoproteins—ALB—type 2 diabetes mellitus	1.21e-06	6.31e-05	CbGpPWpGaD
Pioglitazone—CYP2C9—Metabolism—PSMD6—type 2 diabetes mellitus	1.21e-06	6.29e-05	CbGpPWpGaD
Pioglitazone—CYP2C9—Metabolism—SREBF1—type 2 diabetes mellitus	1.21e-06	6.29e-05	CbGpPWpGaD
Pioglitazone—CYP2C9—Metabolism—SNAP25—type 2 diabetes mellitus	1.21e-06	6.29e-05	CbGpPWpGaD
Pioglitazone—CYP2C19—Metabolism—CYP1A2—type 2 diabetes mellitus	1.2e-06	6.24e-05	CbGpPWpGaD
Pioglitazone—CYP2C19—Metabolism—SLC2A1—type 2 diabetes mellitus	1.2e-06	6.24e-05	CbGpPWpGaD
Pioglitazone—CYP2D6—Metabolism—CTGF—type 2 diabetes mellitus	1.2e-06	6.23e-05	CbGpPWpGaD
Pioglitazone—CYP2C9—Metabolism—CTGF—type 2 diabetes mellitus	1.19e-06	6.17e-05	CbGpPWpGaD
Pioglitazone—CYP2D6—Metabolism—HMGCR—type 2 diabetes mellitus	1.19e-06	6.17e-05	CbGpPWpGaD
Pioglitazone—CYP2C9—Metabolism—HMGCR—type 2 diabetes mellitus	1.18e-06	6.12e-05	CbGpPWpGaD
Pioglitazone—CYP2C19—Metabolism—CYP3A4—type 2 diabetes mellitus	1.17e-06	6.08e-05	CbGpPWpGaD
Pioglitazone—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—type 2 diabetes mellitus	1.16e-06	6.05e-05	CbGpPWpGaD
Pioglitazone—CYP2D6—Metabolism—ADRA2A—type 2 diabetes mellitus	1.16e-06	6.04e-05	CbGpPWpGaD
Pioglitazone—CYP2C9—Metabolism of lipids and lipoproteins—PIK3R1—type 2 diabetes mellitus	1.16e-06	6.03e-05	CbGpPWpGaD
Pioglitazone—CYP3A4—Metabolism—HK1—type 2 diabetes mellitus	1.16e-06	6.03e-05	CbGpPWpGaD
Pioglitazone—SLCO1B1—Metabolism—ALB—type 2 diabetes mellitus	1.16e-06	6e-05	CbGpPWpGaD
Pioglitazone—CYP2C9—Metabolism—ADRA2A—type 2 diabetes mellitus	1.15e-06	5.99e-05	CbGpPWpGaD
Pioglitazone—CYP2C19—Metabolism—GCG—type 2 diabetes mellitus	1.15e-06	5.98e-05	CbGpPWpGaD
Pioglitazone—CYP2C19—Metabolism—SLC2A4—type 2 diabetes mellitus	1.15e-06	5.98e-05	CbGpPWpGaD
Pioglitazone—PTGS1—Metabolism—PPARG—type 2 diabetes mellitus	1.14e-06	5.94e-05	CbGpPWpGaD
Pioglitazone—PTGS1—Metabolism—INS—type 2 diabetes mellitus	1.12e-06	5.83e-05	CbGpPWpGaD
Pioglitazone—CYP3A4—Metabolism—GCKR—type 2 diabetes mellitus	1.12e-06	5.82e-05	CbGpPWpGaD
Pioglitazone—CYP3A4—Metabolism—KCNJ11—type 2 diabetes mellitus	1.12e-06	5.82e-05	CbGpPWpGaD
Pioglitazone—CYP3A4—Metabolism—HSD3B2—type 2 diabetes mellitus	1.12e-06	5.82e-05	CbGpPWpGaD
Pioglitazone—CYP3A4—Metabolism—LPA—type 2 diabetes mellitus	1.12e-06	5.82e-05	CbGpPWpGaD
Pioglitazone—CYP2D6—Metabolism—CYP2E1—type 2 diabetes mellitus	1.12e-06	5.8e-05	CbGpPWpGaD
Pioglitazone—CYP2C8—Metabolism—PPARGC1A—type 2 diabetes mellitus	1.11e-06	5.77e-05	CbGpPWpGaD
Pioglitazone—CYP2C8—Metabolism—GNB3—type 2 diabetes mellitus	1.11e-06	5.77e-05	CbGpPWpGaD
Pioglitazone—CYP2C9—Metabolism—CYP2E1—type 2 diabetes mellitus	1.11e-06	5.75e-05	CbGpPWpGaD
Pioglitazone—CYP2C8—Metabolism—HMOX1—type 2 diabetes mellitus	1.11e-06	5.75e-05	CbGpPWpGaD
Pioglitazone—SLCO1B1—Metabolism—NOS3—type 2 diabetes mellitus	1.11e-06	5.74e-05	CbGpPWpGaD
Pioglitazone—SLCO1B1—Metabolism—PIK3R1—type 2 diabetes mellitus	1.11e-06	5.74e-05	CbGpPWpGaD
Pioglitazone—CYP2D6—Metabolism—CYP1A2—type 2 diabetes mellitus	1.1e-06	5.74e-05	CbGpPWpGaD
Pioglitazone—CYP2D6—Metabolism—SLC2A1—type 2 diabetes mellitus	1.1e-06	5.74e-05	CbGpPWpGaD
Pioglitazone—CYP2C9—Metabolism—SLC2A1—type 2 diabetes mellitus	1.09e-06	5.69e-05	CbGpPWpGaD
Pioglitazone—CYP2C9—Metabolism—CYP1A2—type 2 diabetes mellitus	1.09e-06	5.69e-05	CbGpPWpGaD
Pioglitazone—CYP2C8—Metabolism—CAT—type 2 diabetes mellitus	1.09e-06	5.67e-05	CbGpPWpGaD
Pioglitazone—CYP2D6—Metabolism—CYP3A4—type 2 diabetes mellitus	1.08e-06	5.59e-05	CbGpPWpGaD
Pioglitazone—CYP3A4—Metabolism—ALDOB—type 2 diabetes mellitus	1.07e-06	5.58e-05	CbGpPWpGaD
Pioglitazone—CYP2C9—Metabolism—CYP3A4—type 2 diabetes mellitus	1.07e-06	5.54e-05	CbGpPWpGaD
Pioglitazone—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—type 2 diabetes mellitus	1.06e-06	5.52e-05	CbGpPWpGaD
Pioglitazone—CYP2C8—Metabolism—APOB—type 2 diabetes mellitus	1.06e-06	5.5e-05	CbGpPWpGaD
Pioglitazone—CYP2D6—Metabolism—GCG—type 2 diabetes mellitus	1.06e-06	5.5e-05	CbGpPWpGaD
Pioglitazone—CYP2D6—Metabolism—SLC2A4—type 2 diabetes mellitus	1.06e-06	5.5e-05	CbGpPWpGaD
Pioglitazone—CYP2C9—Metabolism—GCG—type 2 diabetes mellitus	1.05e-06	5.45e-05	CbGpPWpGaD
Pioglitazone—CYP2C9—Metabolism—SLC2A4—type 2 diabetes mellitus	1.05e-06	5.45e-05	CbGpPWpGaD
Pioglitazone—CYP2C8—Metabolism—GSTM1—type 2 diabetes mellitus	1.03e-06	5.35e-05	CbGpPWpGaD
Pioglitazone—PTGS1—Metabolism—ALB—type 2 diabetes mellitus	1.03e-06	5.34e-05	CbGpPWpGaD
Pioglitazone—CYP2C8—Metabolism—LPL—type 2 diabetes mellitus	1.01e-06	5.26e-05	CbGpPWpGaD
Pioglitazone—SLCO1B1—Metabolism—PTGS2—type 2 diabetes mellitus	1.01e-06	5.25e-05	CbGpPWpGaD
Pioglitazone—CYP3A4—Metabolism—GLP1R—type 2 diabetes mellitus	9.98e-07	5.19e-05	CbGpPWpGaD
Pioglitazone—CYP2C19—Metabolism—GNB3—type 2 diabetes mellitus	9.92e-07	5.15e-05	CbGpPWpGaD
Pioglitazone—CYP2C19—Metabolism—PPARGC1A—type 2 diabetes mellitus	9.92e-07	5.15e-05	CbGpPWpGaD
Pioglitazone—CYP2C8—Metabolism—ADCY5—type 2 diabetes mellitus	9.9e-07	5.15e-05	CbGpPWpGaD
Pioglitazone—CYP2C19—Metabolism—HMOX1—type 2 diabetes mellitus	9.87e-07	5.13e-05	CbGpPWpGaD
Pioglitazone—CYP2C8—Metabolism—GPX1—type 2 diabetes mellitus	9.87e-07	5.13e-05	CbGpPWpGaD
Pioglitazone—PTGS1—Metabolism—PIK3R1—type 2 diabetes mellitus	9.83e-07	5.11e-05	CbGpPWpGaD
Pioglitazone—PTGS1—Metabolism—NOS3—type 2 diabetes mellitus	9.83e-07	5.11e-05	CbGpPWpGaD
Pioglitazone—CYP2C19—Metabolism—CAT—type 2 diabetes mellitus	9.74e-07	5.06e-05	CbGpPWpGaD
Pioglitazone—CYP2C8—Metabolism—CD36—type 2 diabetes mellitus	9.61e-07	4.99e-05	CbGpPWpGaD
Pioglitazone—CYP2C8—Metabolism—PPP2CA—type 2 diabetes mellitus	9.49e-07	4.93e-05	CbGpPWpGaD
Pioglitazone—CYP2C19—Metabolism—APOB—type 2 diabetes mellitus	9.46e-07	4.91e-05	CbGpPWpGaD
Pioglitazone—CYP3A4—Metabolism—SLC2A2—type 2 diabetes mellitus	9.32e-07	4.84e-05	CbGpPWpGaD
Pioglitazone—CYP2C19—Metabolism—GSTM1—type 2 diabetes mellitus	9.2e-07	4.78e-05	CbGpPWpGaD
Pioglitazone—CYP3A4—Metabolism—CPT1A—type 2 diabetes mellitus	9.13e-07	4.74e-05	CbGpPWpGaD
Pioglitazone—CYP3A4—Metabolism—MTR—type 2 diabetes mellitus	9.13e-07	4.74e-05	CbGpPWpGaD
Pioglitazone—CYP2D6—Metabolism—GNB3—type 2 diabetes mellitus	9.12e-07	4.74e-05	CbGpPWpGaD
Pioglitazone—CYP2D6—Metabolism—PPARGC1A—type 2 diabetes mellitus	9.12e-07	4.74e-05	CbGpPWpGaD
Pioglitazone—CYP2C8—Metabolism—MTHFR—type 2 diabetes mellitus	9.11e-07	4.73e-05	CbGpPWpGaD
Pioglitazone—CYP2D6—Metabolism—HMOX1—type 2 diabetes mellitus	9.08e-07	4.72e-05	CbGpPWpGaD
Pioglitazone—CYP2C9—Metabolism—PPARGC1A—type 2 diabetes mellitus	9.04e-07	4.7e-05	CbGpPWpGaD
Pioglitazone—CYP2C9—Metabolism—GNB3—type 2 diabetes mellitus	9.04e-07	4.7e-05	CbGpPWpGaD
Pioglitazone—CYP2C19—Metabolism—LPL—type 2 diabetes mellitus	9.03e-07	4.69e-05	CbGpPWpGaD
Pioglitazone—CYP2C9—Metabolism—HMOX1—type 2 diabetes mellitus	9e-07	4.68e-05	CbGpPWpGaD
Pioglitazone—PTGS1—Metabolism—PTGS2—type 2 diabetes mellitus	8.99e-07	4.67e-05	CbGpPWpGaD
Pioglitazone—CYP2D6—Metabolism—CAT—type 2 diabetes mellitus	8.96e-07	4.65e-05	CbGpPWpGaD
Pioglitazone—CYP3A4—Metabolism—NAMPT—type 2 diabetes mellitus	8.95e-07	4.65e-05	CbGpPWpGaD
Pioglitazone—CYP2C8—Metabolism—PPARA—type 2 diabetes mellitus	8.93e-07	4.64e-05	CbGpPWpGaD
Pioglitazone—CYP3A4—Metabolism—LIPC—type 2 diabetes mellitus	8.9e-07	4.62e-05	CbGpPWpGaD
Pioglitazone—CYP3A4—Metabolism—HBA1—type 2 diabetes mellitus	8.9e-07	4.62e-05	CbGpPWpGaD
Pioglitazone—CYP3A4—Metabolism—GCK—type 2 diabetes mellitus	8.9e-07	4.62e-05	CbGpPWpGaD
Pioglitazone—CYP2C9—Metabolism—CAT—type 2 diabetes mellitus	8.88e-07	4.61e-05	CbGpPWpGaD
Pioglitazone—CYP3A4—Metabolism—CYP11A1—type 2 diabetes mellitus	8.84e-07	4.59e-05	CbGpPWpGaD
Pioglitazone—CYP2C19—Metabolism—ADCY5—type 2 diabetes mellitus	8.84e-07	4.59e-05	CbGpPWpGaD
Pioglitazone—CYP2C19—Metabolism—GPX1—type 2 diabetes mellitus	8.81e-07	4.58e-05	CbGpPWpGaD
Pioglitazone—CYP2D6—Metabolism—APOB—type 2 diabetes mellitus	8.7e-07	4.52e-05	CbGpPWpGaD
Pioglitazone—CYP3A4—Metabolism—SLC9A1—type 2 diabetes mellitus	8.68e-07	4.51e-05	CbGpPWpGaD
Pioglitazone—CYP2C8—Metabolism—AGT—type 2 diabetes mellitus	8.65e-07	4.5e-05	CbGpPWpGaD
Pioglitazone—CYP2C9—Metabolism—APOB—type 2 diabetes mellitus	8.62e-07	4.48e-05	CbGpPWpGaD
Pioglitazone—CYP3A4—Metabolism—CETP—type 2 diabetes mellitus	8.58e-07	4.46e-05	CbGpPWpGaD
Pioglitazone—CYP2C19—Metabolism—CD36—type 2 diabetes mellitus	8.58e-07	4.46e-05	CbGpPWpGaD
Pioglitazone—CYP2C8—Metabolism—CALM1—type 2 diabetes mellitus	8.51e-07	4.42e-05	CbGpPWpGaD
Pioglitazone—CYP2C8—Metabolism—APOE—type 2 diabetes mellitus	8.48e-07	4.41e-05	CbGpPWpGaD
Pioglitazone—CYP2C19—Metabolism—PPP2CA—type 2 diabetes mellitus	8.47e-07	4.4e-05	CbGpPWpGaD
Pioglitazone—CYP2D6—Metabolism—GSTM1—type 2 diabetes mellitus	8.46e-07	4.4e-05	CbGpPWpGaD
Pioglitazone—CYP2C9—Metabolism—GSTM1—type 2 diabetes mellitus	8.39e-07	4.36e-05	CbGpPWpGaD
Pioglitazone—CYP2C8—Metabolism—APOA1—type 2 diabetes mellitus	8.38e-07	4.36e-05	CbGpPWpGaD
Pioglitazone—CYP2D6—Metabolism—LPL—type 2 diabetes mellitus	8.3e-07	4.31e-05	CbGpPWpGaD
Pioglitazone—PPARG—Gene Expression—AKT1—type 2 diabetes mellitus	8.3e-07	4.31e-05	CbGpPWpGaD
Pioglitazone—CYP2C9—Metabolism—LPL—type 2 diabetes mellitus	8.23e-07	4.28e-05	CbGpPWpGaD
Pioglitazone—CYP2D6—Metabolism—ADCY5—type 2 diabetes mellitus	8.13e-07	4.22e-05	CbGpPWpGaD
Pioglitazone—CYP2C19—Metabolism—MTHFR—type 2 diabetes mellitus	8.13e-07	4.22e-05	CbGpPWpGaD
Pioglitazone—CYP2D6—Metabolism—GPX1—type 2 diabetes mellitus	8.1e-07	4.21e-05	CbGpPWpGaD
Pioglitazone—CYP2C9—Metabolism—ADCY5—type 2 diabetes mellitus	8.06e-07	4.19e-05	CbGpPWpGaD
Pioglitazone—CYP2C9—Metabolism—GPX1—type 2 diabetes mellitus	8.03e-07	4.17e-05	CbGpPWpGaD
Pioglitazone—CYP3A4—Metabolism—PSMD6—type 2 diabetes mellitus	7.98e-07	4.15e-05	CbGpPWpGaD
Pioglitazone—CYP3A4—Metabolism—SNAP25—type 2 diabetes mellitus	7.98e-07	4.15e-05	CbGpPWpGaD
Pioglitazone—CYP3A4—Metabolism—SREBF1—type 2 diabetes mellitus	7.98e-07	4.15e-05	CbGpPWpGaD
Pioglitazone—CYP2C19—Metabolism—PPARA—type 2 diabetes mellitus	7.98e-07	4.14e-05	CbGpPWpGaD
Pioglitazone—CYP2D6—Metabolism—CD36—type 2 diabetes mellitus	7.89e-07	4.1e-05	CbGpPWpGaD
Pioglitazone—CYP3A4—Metabolism—CTGF—type 2 diabetes mellitus	7.83e-07	4.07e-05	CbGpPWpGaD
Pioglitazone—CYP2C9—Metabolism—CD36—type 2 diabetes mellitus	7.82e-07	4.06e-05	CbGpPWpGaD
Pioglitazone—CYP2D6—Metabolism—PPP2CA—type 2 diabetes mellitus	7.79e-07	4.05e-05	CbGpPWpGaD
Pioglitazone—CYP3A4—Metabolism—HMGCR—type 2 diabetes mellitus	7.76e-07	4.03e-05	CbGpPWpGaD
Pioglitazone—CYP2C9—Metabolism—PPP2CA—type 2 diabetes mellitus	7.72e-07	4.01e-05	CbGpPWpGaD
Pioglitazone—CYP2C19—Metabolism—AGT—type 2 diabetes mellitus	7.72e-07	4.01e-05	CbGpPWpGaD
Pioglitazone—CYP3A4—Metabolism—ADRA2A—type 2 diabetes mellitus	7.6e-07	3.95e-05	CbGpPWpGaD
Pioglitazone—CYP2C19—Metabolism—CALM1—type 2 diabetes mellitus	7.59e-07	3.95e-05	CbGpPWpGaD
Pioglitazone—CYP2C19—Metabolism—APOE—type 2 diabetes mellitus	7.57e-07	3.93e-05	CbGpPWpGaD
Pioglitazone—SLCO1B3—Metabolism—AKT1—type 2 diabetes mellitus	7.56e-07	3.93e-05	CbGpPWpGaD
Pioglitazone—CYP2C19—Metabolism—APOA1—type 2 diabetes mellitus	7.48e-07	3.89e-05	CbGpPWpGaD
Pioglitazone—CYP2D6—Metabolism—MTHFR—type 2 diabetes mellitus	7.48e-07	3.89e-05	CbGpPWpGaD
Pioglitazone—CYP2C9—Metabolism—MTHFR—type 2 diabetes mellitus	7.41e-07	3.85e-05	CbGpPWpGaD
Pioglitazone—CYP2C8—Metabolism—PPARG—type 2 diabetes mellitus	7.39e-07	3.84e-05	CbGpPWpGaD
Pioglitazone—CYP2D6—Metabolism—PPARA—type 2 diabetes mellitus	7.34e-07	3.81e-05	CbGpPWpGaD
Pioglitazone—CYP3A4—Metabolism—CYP2E1—type 2 diabetes mellitus	7.3e-07	3.79e-05	CbGpPWpGaD
Pioglitazone—CYP2C9—Metabolism—PPARA—type 2 diabetes mellitus	7.27e-07	3.78e-05	CbGpPWpGaD
Pioglitazone—CYP2C8—Metabolism—INS—type 2 diabetes mellitus	7.24e-07	3.76e-05	CbGpPWpGaD
Pioglitazone—CYP3A4—Metabolism—CYP1A2—type 2 diabetes mellitus	7.22e-07	3.75e-05	CbGpPWpGaD
Pioglitazone—CYP3A4—Metabolism—SLC2A1—type 2 diabetes mellitus	7.22e-07	3.75e-05	CbGpPWpGaD
Pioglitazone—CYP2D6—Metabolism—AGT—type 2 diabetes mellitus	7.1e-07	3.69e-05	CbGpPWpGaD
Pioglitazone—CYP2C9—Metabolism—AGT—type 2 diabetes mellitus	7.04e-07	3.66e-05	CbGpPWpGaD
Pioglitazone—CYP2D6—Metabolism—CALM1—type 2 diabetes mellitus	6.99e-07	3.63e-05	CbGpPWpGaD
Pioglitazone—CYP2D6—Metabolism—APOE—type 2 diabetes mellitus	6.96e-07	3.62e-05	CbGpPWpGaD
Pioglitazone—CYP2C9—Metabolism—CALM1—type 2 diabetes mellitus	6.92e-07	3.6e-05	CbGpPWpGaD
Pioglitazone—CYP3A4—Metabolism—SLC2A4—type 2 diabetes mellitus	6.92e-07	3.6e-05	CbGpPWpGaD
Pioglitazone—CYP3A4—Metabolism—GCG—type 2 diabetes mellitus	6.92e-07	3.6e-05	CbGpPWpGaD
Pioglitazone—CYP2C9—Metabolism—APOE—type 2 diabetes mellitus	6.9e-07	3.59e-05	CbGpPWpGaD
Pioglitazone—CYP2D6—Metabolism—APOA1—type 2 diabetes mellitus	6.88e-07	3.58e-05	CbGpPWpGaD
Pioglitazone—CYP2C9—Metabolism—APOA1—type 2 diabetes mellitus	6.82e-07	3.54e-05	CbGpPWpGaD
Pioglitazone—CYP2C8—Metabolism—ALB—type 2 diabetes mellitus	6.64e-07	3.45e-05	CbGpPWpGaD
Pioglitazone—CYP2C19—Metabolism—PPARG—type 2 diabetes mellitus	6.59e-07	3.43e-05	CbGpPWpGaD
Pioglitazone—CYP2C19—Metabolism—INS—type 2 diabetes mellitus	6.47e-07	3.36e-05	CbGpPWpGaD
Pioglitazone—PPARG—Metabolism—AKT1—type 2 diabetes mellitus	6.45e-07	3.35e-05	CbGpPWpGaD
Pioglitazone—CYP2C8—Metabolism—PIK3R1—type 2 diabetes mellitus	6.35e-07	3.3e-05	CbGpPWpGaD
Pioglitazone—CYP2C8—Metabolism—NOS3—type 2 diabetes mellitus	6.35e-07	3.3e-05	CbGpPWpGaD
Pioglitazone—CYP2D6—Metabolism—PPARG—type 2 diabetes mellitus	6.06e-07	3.15e-05	CbGpPWpGaD
Pioglitazone—CYP2C9—Metabolism—PPARG—type 2 diabetes mellitus	6.01e-07	3.12e-05	CbGpPWpGaD
Pioglitazone—CYP3A4—Metabolism—GNB3—type 2 diabetes mellitus	5.96e-07	3.1e-05	CbGpPWpGaD
Pioglitazone—CYP3A4—Metabolism—PPARGC1A—type 2 diabetes mellitus	5.96e-07	3.1e-05	CbGpPWpGaD
Pioglitazone—CYP2D6—Metabolism—INS—type 2 diabetes mellitus	5.95e-07	3.09e-05	CbGpPWpGaD
Pioglitazone—CYP3A4—Metabolism—HMOX1—type 2 diabetes mellitus	5.94e-07	3.08e-05	CbGpPWpGaD
Pioglitazone—CYP2C19—Metabolism—ALB—type 2 diabetes mellitus	5.93e-07	3.08e-05	CbGpPWpGaD
Pioglitazone—CYP2C9—Metabolism—INS—type 2 diabetes mellitus	5.9e-07	3.06e-05	CbGpPWpGaD
Pioglitazone—CYP3A4—Metabolism—CAT—type 2 diabetes mellitus	5.86e-07	3.04e-05	CbGpPWpGaD
Pioglitazone—CYP2C8—Metabolism—PTGS2—type 2 diabetes mellitus	5.81e-07	3.02e-05	CbGpPWpGaD
Pioglitazone—CYP3A4—Metabolism—APOB—type 2 diabetes mellitus	5.69e-07	2.95e-05	CbGpPWpGaD
Pioglitazone—CYP2C19—Metabolism—PIK3R1—type 2 diabetes mellitus	5.67e-07	2.95e-05	CbGpPWpGaD
Pioglitazone—CYP2C19—Metabolism—NOS3—type 2 diabetes mellitus	5.67e-07	2.95e-05	CbGpPWpGaD
Pioglitazone—CYP3A4—Metabolism—GSTM1—type 2 diabetes mellitus	5.53e-07	2.87e-05	CbGpPWpGaD
Pioglitazone—CYP2D6—Metabolism—ALB—type 2 diabetes mellitus	5.45e-07	2.83e-05	CbGpPWpGaD
Pioglitazone—CYP3A4—Metabolism—LPL—type 2 diabetes mellitus	5.43e-07	2.82e-05	CbGpPWpGaD
Pioglitazone—CYP2C9—Metabolism—ALB—type 2 diabetes mellitus	5.4e-07	2.81e-05	CbGpPWpGaD
Pioglitazone—CYP3A4—Metabolism—ADCY5—type 2 diabetes mellitus	5.32e-07	2.76e-05	CbGpPWpGaD
Pioglitazone—CYP3A4—Metabolism—GPX1—type 2 diabetes mellitus	5.3e-07	2.75e-05	CbGpPWpGaD
Pioglitazone—CYP2D6—Metabolism—PIK3R1—type 2 diabetes mellitus	5.21e-07	2.71e-05	CbGpPWpGaD
Pioglitazone—CYP2D6—Metabolism—NOS3—type 2 diabetes mellitus	5.21e-07	2.71e-05	CbGpPWpGaD
Pioglitazone—CYP2C19—Metabolism—PTGS2—type 2 diabetes mellitus	5.19e-07	2.69e-05	CbGpPWpGaD
Pioglitazone—CYP2C9—Metabolism—PIK3R1—type 2 diabetes mellitus	5.17e-07	2.69e-05	CbGpPWpGaD
Pioglitazone—CYP2C9—Metabolism—NOS3—type 2 diabetes mellitus	5.17e-07	2.69e-05	CbGpPWpGaD
Pioglitazone—CYP3A4—Metabolism—CD36—type 2 diabetes mellitus	5.16e-07	2.68e-05	CbGpPWpGaD
Pioglitazone—CYP3A4—Metabolism—PPP2CA—type 2 diabetes mellitus	5.09e-07	2.65e-05	CbGpPWpGaD
Pioglitazone—SLCO1B1—Metabolism—AKT1—type 2 diabetes mellitus	5.08e-07	2.64e-05	CbGpPWpGaD
Pioglitazone—CYP3A4—Metabolism—MTHFR—type 2 diabetes mellitus	4.89e-07	2.54e-05	CbGpPWpGaD
Pioglitazone—CYP3A4—Metabolism—PPARA—type 2 diabetes mellitus	4.8e-07	2.49e-05	CbGpPWpGaD
Pioglitazone—CYP2D6—Metabolism—PTGS2—type 2 diabetes mellitus	4.77e-07	2.48e-05	CbGpPWpGaD
Pioglitazone—CYP2C9—Metabolism—PTGS2—type 2 diabetes mellitus	4.73e-07	2.46e-05	CbGpPWpGaD
Pioglitazone—CYP3A4—Metabolism—AGT—type 2 diabetes mellitus	4.64e-07	2.41e-05	CbGpPWpGaD
Pioglitazone—CYP3A4—Metabolism—CALM1—type 2 diabetes mellitus	4.57e-07	2.37e-05	CbGpPWpGaD
Pioglitazone—CYP3A4—Metabolism—APOE—type 2 diabetes mellitus	4.55e-07	2.36e-05	CbGpPWpGaD
Pioglitazone—PTGS1—Metabolism—AKT1—type 2 diabetes mellitus	4.52e-07	2.35e-05	CbGpPWpGaD
Pioglitazone—CYP3A4—Metabolism—APOA1—type 2 diabetes mellitus	4.5e-07	2.34e-05	CbGpPWpGaD
Pioglitazone—CYP3A4—Metabolism—PPARG—type 2 diabetes mellitus	3.96e-07	2.06e-05	CbGpPWpGaD
Pioglitazone—CYP3A4—Metabolism—INS—type 2 diabetes mellitus	3.89e-07	2.02e-05	CbGpPWpGaD
Pioglitazone—CYP3A4—Metabolism—ALB—type 2 diabetes mellitus	3.56e-07	1.85e-05	CbGpPWpGaD
Pioglitazone—CYP3A4—Metabolism—NOS3—type 2 diabetes mellitus	3.41e-07	1.77e-05	CbGpPWpGaD
Pioglitazone—CYP3A4—Metabolism—PIK3R1—type 2 diabetes mellitus	3.41e-07	1.77e-05	CbGpPWpGaD
Pioglitazone—CYP3A4—Metabolism—PTGS2—type 2 diabetes mellitus	3.12e-07	1.62e-05	CbGpPWpGaD
Pioglitazone—CYP2C8—Metabolism—AKT1—type 2 diabetes mellitus	2.92e-07	1.52e-05	CbGpPWpGaD
Pioglitazone—CYP2C19—Metabolism—AKT1—type 2 diabetes mellitus	2.61e-07	1.35e-05	CbGpPWpGaD
Pioglitazone—CYP2D6—Metabolism—AKT1—type 2 diabetes mellitus	2.4e-07	1.25e-05	CbGpPWpGaD
Pioglitazone—CYP2C9—Metabolism—AKT1—type 2 diabetes mellitus	2.38e-07	1.23e-05	CbGpPWpGaD
Pioglitazone—CYP3A4—Metabolism—AKT1—type 2 diabetes mellitus	1.57e-07	8.14e-06	CbGpPWpGaD
